Skip to main content
. 2013 Oct 19;13(4):243–252. doi: 10.1007/s40268-013-0029-1

Table 1.

Baseline demographics of safety and mITT populations

Safety population mITT population
Besifloxacin (n = 344) Vehicle (n = 170) Besifloxacin (n = 212) Vehicle (n = 87)
Age, years
 Mean (SD) 29.6 (25.1) 30.5 (22.5) 27.8 (25.4) 28.5 (21.1)
 Range 1–97 1–92 1–97 1–74
Distribution of age categories, n (%)
 ≥1–<2 years 19 (5.5) 8 (4.7) 19 (9.0) 6 (6.9)
 2–11 years 107 (31.1) 38 (22.4) 71 (33.5) 21 (24.1)
 12–17 years 22 (6.4) 14 (8.2) 9 (4.2) 5 (5.7)
 18–29 years 46 (13.4) 29 (17.1) 27 (12.7) 13 (14.9)
 30–39 years 30 (8.7) 23 (13.5) 16 (7.5) 13 (14.9)
 40–49 years 29 (8.4) 20 (11.8) 17 (8.0) 12 (13.8)
 50–59 years 38 (11.0) 20 (11.8) 20 (9.4) 10 (11.5)
 ≥60 years 53 (15.4) 18 (10.6) 33 (15.6) 7 (8.0)
Sex, n (%)
 Male 140 (40.7) 75 (44.1) 87 (41.0) 38 (43.7)
 Female 204 (59.3) 95 (55.9) 125 (59.0) 49 (56.3)
Racial background, n (%)
 American Indian/Alaskan Native 7 (2.0) 3 (1.8) 5 (2.4) 1 (1.1)
 Asian 5 (1.5) 5 (2.9) 3 (1.4) 2 (2.3)
 Black/African American 83 (24.1) 40 (23.5) 65 (30.7) 30 (34.5)
 Native Hawaiian/Pacific Islander 0 1 (0.6) 0 0
 White 210 (61.0) 102 (60.0) 121 (57.1) 49 (56.3)
 Other 39 (11.3) 19 (11.2) 18 (8.5) 5 (5.7)
Ethnicity, n (%)
 Not Hispanic and Not Latino 194 (56.4) 101 (59.4) 126 (59.4) 58 (66.7)
 Hispanic or Latino 150 (43.6) 69 (40.6) 86 (40.6) 29 (33.3)

mITT modified Intent to Treat population